Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Cancer Letters · 2024-04 · 588 · 216799
DOI: 10.1016/j.canlet.2024.216799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-04. Verfasst von Siao Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Proteome Research Center, Beijing Institute of Radiation…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Bile Duct Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Nova Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
As two major types of primary liver cancers, the tumor immune microenvironment (TIME) of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have been well studied separately. However, a systemic assessment of the similarities and differences between the TIME of HCC and ICC is still lacking. In this study, we pictured a landscape of combined TIME of HCC and ICC by sequencing and integrating 41 single-cell RNA-seq samples from four different tissue types of both malignancies. We found that T cells in HCC tumors generally exhibit higher levels of immunosuppression and exhaustion than those in ICC tumors. Myeloid cells in HCC and ICC tumors also exhibit distinct phenotypes and may serve as a key factor driving the differences between their TIMEs. Besides, we identified a cluster of EGR1+ macrophages specifically enriched in HCC tumors. Together, our study provides new insights into cellular composition, states and interactions in the TIMEs of HCC and ICC, which could pave the way for the development of future therapeutic targets for liver cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, PR China; School of Life Science, University of He…
- State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, PR China.
- Department of Hepatobiliary Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, PR China.
- College of Xinjiang Uyghur Medicine, Hetian City, Xinjiang Province, PR China.
- State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, PR China; Collaborative Innovation Center for Pers…
- State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, PR China; Medical College, Guizhou University, Gui…
Förderung
- Beijing Nova Program
- National Natural Science Foundation of China
Zitieren
APA
Jiang, S., Lu, H., Pan, Y., Yang, A., Aikemu, A., Li, H., Hao, R., Huang, Q., Qi, X., Tao, Z., Wu, Y., Quan, C., Zhou, G., & Lu, Y. (2024). Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Letters, 588, 216799. https://doi.org/10.1016/j.canlet.2024.216799
Vancouver
Jiang S, Lu H, Pan Y, Yang A, Aikemu A, Li H, et al. Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Letters. 2024;588:216799. doi:10.1016/j.canlet.2024.216799
BibTeX
@article{Jiang2024,
author = {Jiang, Siao and Lu, Hao and Pan, Yingwei and Yang, Aiqing and Aikemu, Ainiwaer and Li, Hao and Hao, Rongjiao and Huang, Qilin and Qi, Xin and Tao, Zongjian and Wu, Yinglong and Quan, Cheng and Zhou, Gangqiao and Lu, Yiming},
title = {Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma},
journal = {Cancer Letters},
year = {2024},
volume = {588},
pages = {216799},
doi = {10.1016/j.canlet.2024.216799}
}
EUVIMED